NTRA
Natera Inc.
Price performance
Sep 18, 2026About
Company activity
25 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/06 | NTRA | 8-K | Natera Reports Strong Q2 2026 Financial Results and Raises Annual Guidance | — | — | — |
| 07/06 | NTRA | 8-K | Natera Board Member Monica Bertagnolli Resigns | — | — | — |
| 06/16 | NTRA | 8-K | Natera, Inc. Approves Amendment to Equity Incentive Plan at Annual Meeting | — | — | — |
| 06/05 | NTRA | 8-K | Natera Appoints New Director Thomas Lynch | — | — | — |
| 05/07 | NTRA | 8-K | Natera Reports Strong Q1 2026 Financial Results and Raises Annual Guidance | — | — | — |
| 04/01 | NTRA | 8-K | Natera Appoints New Director Eric Rubin | — | — | — |
| 02/26 | NTRA | 8-K | Natera Reports Strong 2025 Financial Results | — | — | — |
| 01/12 | NTRA | 8-K | Natera Announces Preliminary 2025 Financial Results with Strong Growth | — | — | — |
| 12/05/25 | NTRA | 8-K | Natera Acquires Foresight Diagnostics for $450M | — | — | — |
| 11/06/25 | NTRA | 8-K | Natera Reports Strong Third Quarter 2025 Financial Results | — | — | — |
| 08/07/25 | NTRA | 8-K | Natera Announces Strong Second Quarter 2025 Financial Results and Raises Outlook | — | — | — |
| 06/18/25 | NTRA | 8-K | Natera, Inc. Stockholders Approve Equity Incentive Plan Amendment | — | — | — |
| 05/08/25 | NTRA | 8-K | Natera Reports Strong Q1 2025 Financial Results | — | — | — |
| 03/12/25 | NTRA | 8-K | Natera Appoints New Board Member and Increases Board Size | — | — | — |
| 02/27/25 | NTRA | 8-K | Natera Reports Strong Q4 and Full Year 2024 Financial Results with Significant Revenue Growth | — | — | — |
| 01/13/25 | NTRA | 8-K | Natera Announces Strong Preliminary Q4 and Full-Year 2024 Financial Results | — | — | — |
| 12/06/24 | NTRA | 8-K | Amended Employment Agreement for Executive Chairman | — | — | — |
| 11/12/24 | NTRA | 8-K | Natera Announces Strong Third Quarter 2024 Financial Results | — | — | — |
| 08/08/24 | NTRA | 8-K | Natera Reports Strong Q2 2024 Financial Results | — | — | — |
| 07/22/24 | NTRA | 8-K | Natera Announces Redemption of Convertible Senior Notes | — | — | — |
| 06/18/24 | NTRA | 8-K | Natera Inc. Approves Amended Equity Incentive Plan | — | — | — |
| 05/09/24 | NTRA | 8-K | Natera Reports Strong First Quarter 2024 Financial Results | — | — | — |
| 02/28/24 | NTRA | 8-K | Natera Reports Strong Financial Results for Q4 and Full Year 2023 | — | — | — |
| 01/22/24 | NTRA | 8-K | Natera Acquires Invitae's Non-Invasive Prenatal and Carrier Screening Business | — | — | — |
| 01/09/24 | NTRA | 8-K | Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues | — | — | — |
NTRA filing record
Natera Inc. (NTRA): 25 8-K filings summarized, the most recent on Aug 6, 2026.
What the 8-K filings said
- Aug 6, 2026 · high impact
Natera, Inc. reported its second quarter 2026 financial results, showing a 37.7% increase in total revenues to $752.8 million, driven by higher test volumes and average selling price improvements. The company processed approximately 1.04 million tests, a 22.4% increase from the prior year. Natera also raised its 2026…
Natera Reports Strong Q2 2026 Financial Results and Raises Annual Guidance - Jul 6, 2026 · medium impact
On July 1, 2026, Monica Bertagnolli notified the Board of Directors of Natera, Inc. of her intention to resign as a member of the Board and any committees of the Board, effective July 1, 2026, due to her new position with the National Academy of Medicine. Ms. Bertagnolli's resignation was not a result of any…
Natera Board Member Monica Bertagnolli Resigns - Jun 16, 2026 · medium impact
On June 11, 2026, Natera, Inc. held its Annual Meeting of Stockholders where the Company's stockholders approved an amendment to the Amended and Restated 2015 Equity Incentive Plan, increasing the shares reserved for issuance by 3.2 million shares. The amendment was approved by a significant majority of the votes…
Natera, Inc. Approves Amendment to Equity Incentive Plan at Annual Meeting - Jun 5, 2026 · high impact
Natera, Inc. announced the appointment of Thomas Lynch as a new member of its Board of Directors, effective June 2, 2026. The Board has also increased its size from eleven to twelve members. Dr. Lynch will serve as a Class I director with an initial term expiring at the 2028 annual meeting of stockholders. He will be…
Natera Appoints New Director Thomas Lynch - May 7, 2026 · high impact
Natera, Inc. reported a 38.8% increase in total revenues to $696.6 million for the first quarter of 2026, compared to $501.8 million in Q1 2025. The company processed approximately 1,013,600 tests, a 18.5% increase from the prior year. Natera also raised its 2026 annual revenue guidance by $120 million at the…
Natera Reports Strong Q1 2026 Financial Results and Raises Annual Guidance
SEC filings in the last five years
- 39 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K